Surgery Partners, Inc.

NASDAQ:SGRY

Medical - Care Facilities

Healthcare
$26.96 +0.39%

+$0.06 today

Market cap
$3.53B
Beta
1.95
P/E (TTM)
-24.1
EPS (TTM)
-$0.59
52W Low $11.41High $24.10

Volume 3.24M

Average 1.36M

SGRY EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Surgery Partners, Inc.NASDAQ: SGRY

EBITDA · Q3 FY2026 · quarter ended Sep 2026

EBITDA declines year over year

Q3 FY2026 EBITDA of $125.2M fell 69.1% year over year, behind the -18.3% change in trailing-twelve-month EBITDA. Sequentially, it fell 11.5% from the prior quarter. Over 3 fiscal years it compounded at +7.1% a year.

Context

  • EBITDA amounted to 17.1% of revenue in FY2025, up 1.0 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 5 analysts of $442.25M (-21.8%) for the fiscal year ending Dec 2026, a slowdown from the +12.8% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$125.2M-11.5% QoQ
Last fiscal yearDec 2025
$565.5M+12.8% YoY
LTMSep 2026
$667.4M-18.3% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-69.1%-46.7%+22.4 pp
1 year+12.8%-21.8%-34.6 pp
3-year CAGR+7.1%-8.0%-15.1 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
565.5M USD
Year-over-year change
+12.8%
4-year CAGR
+9.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How SGRY compares with its peers on the latest reported figures

  • SGRY's LTM Sep 2026 EBITDA of $667.4M is the 5th highest of the 7 companies compared; the peer median is $3.89B.
  • Its year-over-year change of -18.3% is the lowest of 7, against a peer median of +13.2%.
  • EBITDA amounts to 19.9% of revenue for SGRY, versus a peer median of 21.7%.
SGRY Competitors Peer median
EBITDA for SGRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$15.84B +10.3%+5.5%20.3%
THCTenet Healthcare CorporationLTM Jun 2026$5.06B +9.6%+13.4%23.2%
CYHCommunity Health Systems, Inc.LTM Mar 2026$4.96B +296.6%+20.0%23.1%
UHSUniversal Health Services, Inc.LTM Jun 2026$2.82B +16.2%+20.3%15.6%
SGRYSurgery Partners, Inc.LTM Sep 2026$667.4M -18.3%+7.1%19.9%
ARDTArdent Health Partners, LLCLTM Mar 2026$505.76M -10.5%-2.2%7.9%
NUTXNutex Health, Inc.LTM Mar 2026$291.89M +36.3%—33.2%
Peer median (excluding SGRY) $3.89B+13.2%+13.4%21.7%

Competitors are the stored peer set for SGRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.23B2.54B2.74B3.11B3.31B
Cost of Revenue1.73B1.96B2.1B2.37B2.54B
Gross Profit491.4M574.9M647.5M745.6M765M
Gross Margin22.1%22.6%23.6%23.9%23.1%
Research & Development00000
Selling, General & Admin104M102.2M120.9M138.7M522.7M
Operating Expenses189.2M229.7M319.5M396.8M375.5M
Depreciation & Amortization98.8M114.8M118.1M152.6M176M
EBITDA401M460M446.1M501.4M565.5M
EBITDA Margin18.0%18.1%16.3%16.1%17.1%
Operating Income302.2M345.2M328M348.8M389.5M
Operating Margin13.6%13.6%12.0%11.2%11.8%
Interest Income00000
Interest Expense221M234.9M193M201.7M272.6M
Other Income / Expenses(221M)(234.9M)(193M)(201.7M)(272.6M)
Income Before Tax81.2M110.3M135M147.1M116.9M
Pre-Tax Margin3.6%4.3%4.9%4.7%3.5%
Income Tax Expense10.5M23.3M(300K)134.6M18M
Net Income(70.9M)(54.6M)(11.9M)(168.1M)(77.9M)
Net Margin-3.2%-2.2%-0.4%-5.4%-2.4%
EPS (Basic)(1.12)(0.59)(0.09)(1.33)(0.61)
EPS (Diluted)(1.12)(0.59)(0.09)(1.33)(0.61)
Weighted Avg Shares72.43M91.95M125.61M126.12M127.21M
Weighted Avg Shares (Diluted)72.43M91.95M125.61M126.12M127.21M

Surgery Partners, Inc.

NASDAQ:SGRY

Intrinsic Alpha fair value

Locked

Current Price

$26.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.